Vaxart Provides Business Update and Reports Third Quarter 2024 Financial Results
Vaxart, Inc. Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b study in November 2024...
Reports
Meituan reports robust growth and strategic expansions in Q2 2024 By Investing.com
Meituan (3690.HK), the Chinese e-commerce platform, has reported a solid performance in the second quarter of 2024, with a 21%...
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Cue Biopharma, Inc.BOSTON, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel...
Adicet Reports Second Quarter 2024 Financial Results and Provides Business Updates
ADI-001 autoimmune clinical development expanded beyond lupus nephritis (LN) to include systemic lupus erythematosus (SLE), systemic sclerosis (SSc) and anti-neutrophil...
Absci Reports Business Updates and Second Quarter 2024 Financial and Operating Results
Absci CorporationReleased results from non-human primate studies for ABS-101, demonstrating 2-3x extended half-life as compared to antibodies in clinical developmentEntered...
